Potential of Various Drugs to Inhibit Nucleoside Uptake in Rat Syncytiotrophoblast Cell Line, TR-TBT 18d-1

Placenta

Volumn 29, Issue 5, 2008, Pages 461-467

  Chishu, T ^a   Sai, Y ^a   Nishimura, T ^a   Sato, K ^a   Kose, N ^a   Nakashima, E ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Adenosine; Drug interaction; Nucleoside; Placental barrier; Transport; Trophoblast; Uridine

Indexed keywords

ADENOSINE; ALLOPURINOL; AMITRIPTYLINE; BUCLADESINE; CAFFEINE; CYTARABINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; MIZORIBINE; NITROBENZYLTHIOINOSINE; PROPYLTHIOURACIL; PROTEIN SLC29; SODIUM ION; THEOPHYLLINE; TRITIUM; URIDINE; VIDARABINE; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; DRUG INHIBITION; DRUG UPTAKE; IC 50; ISOTOPE LABELING; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNCYTIOTROPHOBLAST;

ANIMALS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; IMMUNOSUPPRESSIVE AGENTS; NUCLEOSIDES; RATS; THIOINOSINE; TRITIUM; TROPHOBLASTS;

EID: 43049106776     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.01.010     Document Type: Article

References (45)

1. Dancis J., Lee J., Mendoza S., and Liebes L. Nucleoside transport by perfused human placenta. Placenta 14 (1993) 547-554
2. Dancis J., Lee J.D., Mendoza S., and Liebes L. Transfer and metabolism of dideoxyinosine by the perfused human placenta. J Acquir Immune Defic Syndr 6 (1993) 2-6
3. Gilstrap L.C., Bawdon R.E., Roberts S.W., and Sobhi S. The transfer of the nucleoside analog ganciclovir across the perfused human placenta. Am J Obstet Gynecol 170 (1994) 967-972
4. Acevedo C.G., and Yudilevich D.L. Transport and metabolism of adenosine in the perfused human placenta. Placenta 16 (1995) 611-622
5. Sudhakaran S., Ghabrial H., Nation R.L., Kong D.C., Gude N.M., Angus P.W., et al. Differential bidirectional transfer of indinavir in the isolated perfused human placenta. Antimicrob Agents Chemother 49 (2005) 1023-1028
6. Barros L.F., Bustamante J.C., Yudilevich D.L., and Jarvis S.M. Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast. J Membr Biol 119 (1991) 151-161
7. Podgorska M., Kocbuch K., and Pawelczyk T. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim Pol 52 4 (2005) 749-758
8. Baldwin S.A., Mackey J.R., Cass C.E., and Young J.D. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5 (1999) 216-224
9. Nishimura M., and Naito S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 20 6 (2005) 452-477
10. Leazer T.M., and Klaassen C.D. The presence of xenobiotic transporters in rat placenta. Drug Metab Dispos 31 2 (2003) 153-167
11. Griffith D.A., and Jarvis S.M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286 (1996) 153-181
12. Ward J.L., Sherali A., Mo Z.P., and Tse C.M. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 24 (2000) 8375-8381
13. Kiss A., Farah K., Kim J., Garriock R.J., Drysdale T.A., and Hammond J.R. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J 352 (2000) 363-372
14. Leung G.P., Ward J.L., Wong P.Y., and Tse C.M. Characterization of nucleoside transport systems in cultured rat epididymal epithelium. Am J Physiol Cell Physiol 280 (2001) C1076-C1082
15. Barros L.F., Yudilevich D.L., Jarvis S.M., Beaumont N., Young J.D., and Baldwin S.A. Immunolocalization of nucleoside transporters in human placental trophoblast and endothelial cells: evidence for multiple transporter isoforms. Pflugers Arch 429 (1995) 394-399
16. Hyde R.J., Cass C.E., Young J.D., and Baldwin S.A. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18 1 (2001) 53-63
17. Acimovic Y., and Coe I.R. Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes. Mol Biol Evol 19 12 (2002) 2199-2210
18. Baldwin S.A., Yao S.Y., Hyde R.J., Ng A.M., Foppolo S., Barnes K., et al. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280 (2005) 15880-15887
19. Barnes K., Dobrzynski H., Foppolo S., Beal P.R., Ismat F., Scullion E.R., et al. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 99 (2006) 510-519
20. +-nucleoside cotransporter (hCNT1). Am J Physiol 272 (1997) C207-C214
21. +-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276 (2001) 2914-2927
22. Griffiths M., Beaumont N., Yao S.Y., Sundaram M., Boumah C.E., Davies A., et al. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 3 (1997) 89-93
23. Crawford C.R., Cass C.E., Young J.D., and Belt J.A. Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line. Biochem Cell Biol 76 (1998) 843-851
24. Graham K.A., Leithoff J., Coe I.R., Mowles D., Mackey J.R., Young J.D., et al. Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1. Nucleosides Nucleotides Nucleic Acids 19 (2000) 415-434
25. Yao S.Y., Ng A.M., Sundaram M., Cass C.E., Baldwin S.A., and Young J.D. Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol Membr Biol 18 (2001) 161-167
26. Vickers M.F., Kumar R., Visser F., Zhang J., Charania J., Raborn R.T., et al. Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae. Biochem Cell Biol 80 (2002) 639-644
27. Cano-Soldado P., Lorrayoz I.M., Molina-Arcas M., Casado F.J., Martinez-Picado J., Lostao M.P., et al. Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter 1 (SLC28A1). Antivir Ther 9 (2004) 993-1002
28. Sibley C.P., Coan P.M., Ferguson-Smith A.C., Dean W., Hughes J., Smith P., et al. Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci USA 101 (2004) 8204-8208
29. Mayhew T.M., Jackson M.R., and Boyd P.A. Changes in oxygen diffusive conductances of human placentae during gestation (10-41 weeks) are commensurate with the gain in fetal weight. Placenta 14 1 (1993) 51-61
30. Mayhew T.M. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodeling of vascular endothelial cells. Placenta 23 10 (2002) 742-750
31. Kitano T., Iizasa H., Terasaki T., Asashima T., Matsunaga N., Utoguchi N., et al. Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs. J Cell Physiol 193 (2002) 208-218
32. Brunton L.L., Lazo J.S., and Parker K.L. Goodman & Gilman's The pharmacological basis of therapeutics. 11th ed. (2006), McGraw-Hill, New York 1794-1888
33. Kawahara M., Kagiyama H., Kanazawa Y., Tsuchiya H., Tomita K., Yokogawa K., et al. Rapid determination method of caffeine and application to monitoring of caffeine-assisted chemotherapy. Biopharm Drug Dispos 25 2 (2004) 61-67
34. Yao S.Y., Ng A.M., Muzyka W.R., Griffiths M., Cass C.E., Baldwin S.A., et al. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 7 (1997) 28423-28430
35. Kato R., Maeda T., Akaike T., and Tamai I. Nucleoside transport at the blood-testis barrier studied with primary-cultured Sertoli cells. J Pharmacol Exp Ther 312 2 (2005) 601-608
36. Ontyd J., and Schrader J. Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr 307 (1984) 404-409
37. Saito H., Nishimura M., Shinano H., Makita H., Tsujino I., Shibuya E., et al. Plasma concentration of adenosine during normoxia and moderate hypoxia in humans. Am J Respir Crit Care Med 159 (1999) 1014-1018
38. Murakami H., Ohkura A., Takanaga H., Matsuo H., Koyabu N., Naito M., et al. Functional characterization of adenosine transport across the BBB in mice. Int J Pharm 16 (2005) 37-44
39. Leung G.P., Man R.Y., and Tse C.M. d-Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 288 (2005) H2756-H2762
40. Nagai K., Nagasawa K., and Fujimoto S. Transport mechanisms for adenosine and uridine in primary-cultured rat cortical neurons and astrocytes. Biochem Biophys Res Commun 9 (2005) 1343-1350
41. Nagase K., Tomi M., Tachikawa M., and Hosoya K. Functional and molecular characterization of adenosine transport at the rat inner blood-retinal barrier. Biochim Biophys Acta 1758 (2006) 13-19
42. Lang T.T., Young J.D., and Cass C.E. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporter 1 and 2 stably produced in a transport-defective human cell line. Mol Pharmacol 65 (2004) 925-933
43. Gati W.P., Misra H.K., Knaus E.E., and Wiebe L.I. Structural modifications at the 2′- and 3′-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter. Biochem Pharmacol 33 (1984) 3325-3331
44. Chang C., Swaan P.W., Ngo L.Y., Lum P.Y., Patil S.D., and Unadkat J.D. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1. Mol Pharmacol 65 (2004) 558-570
45. Vickers M.F., Zhang J., Visser F., Tackaberry T., Robins M.J., Nielsen L.P., et al. Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae. Nucleosides Nucleotides Nucleic Acids 23 (2004) 361-373